Chondrosarcoma Doctors Abroad — Page 2

Professor Keil leads the Clinic for Diagnostic and Interventional Radiology at Academic Hospital Solingen, specializing in advanced imaging for complex cases.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided interventions
• Former leading doctor at University Hospital of Aachen
• Specializes in cross-sectional imaging for all body regions

Director of pediatric hematology oncology at Sourasky Medical Center – specializes in bone cancer treatment for children.

• Expert in sarcoma treatment for children
• Trained at Rizzoli Orthopaedic Institute – a world-leading center
• Coordinates bone cancer treatment with oncology-orthopedic teams
• Member of ISPHO – Israel's pediatric hemato-oncology association

Dr. Yildiz specializes in neuroendocrine tumors and has authored 17+ international peer-reviewed articles, including on chondrosarcoma-related conditions.

• Published research on rare tumor cases like paraneoplastic pemphigus and thymoma
• Expertise in diagnosing and managing complex endocrine-related cancers
• Works at Medipol Mega University Hospital – a leading Turkish medical center

Heads a department dedicated to metastatic bone lesions at Ichilov Medical Center – one of Israel's largest hospitals.

• Specializes exclusively in oncological orthopedics, treating bone cancers.
• Completed advanced clinical internships in Israel and the United States.
• Holds a senior academic position as a Professor at Tel Aviv University.
• Educated at the prestigious Hebrew University of Jerusalem.

Dr. Amir is a specialist in limb-sparing surgery for bone and soft tissue cancers at Israel's Sourasky Medical Center (Ichilov).

• Fellowship-trained in orthopedic oncology at the US National Cancer Institute and the University of Toronto
• Active member of the American Musculoskeletal Tumor Society (MSTS) and the International Society of Limb Salvage (ISOLS)
• Multiple award winner, including the Tannenbaum Grant for Excellence in Surgical Oncology
• Focuses on sarcomas, with expertise in complex cases requiring reconstructive techniques

Prof. Köstler specializes in targeted cancer therapies, with over two decades of experience in individualized cancer treatment at Wiener Privatklinik.

• Expert in breast cancer and gynecologic malignancies
• Associate Professor at the Medical University of Vienna
• Focuses on biomarker development and tumor biology
• Active participant in European oncology networks

Specializing in virotherapy – one of the newest immunology fields – Dr. Jaunalksne brings 49 years of experience of experience to treating chondrosarcoma.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunological approaches to cancer treatment

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Dr. Alemdar specializes in chondrosarcoma at Medical Park Antalya, bringing focused oncology expertise to rare bone cancer cases.

• Board-certified in medical oncology with extensive training
• Experience across multiple prestigious Turkish university hospitals
• Specialized in internal medicine before oncology specialization

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Nail Paksoy brings specialized expertise in bone sarcomas from Istanbul University Oncology Institute, now leading chondrosarcoma care at Medipol Bahçelievler Hospital.

• Board-certified in medical oncology by ESMO
• Authored key research on high-dose chemotherapy for Ewing's sarcoma and other bone tumors
• Participated in international trials for NTRK-fusion solid tumors
• Fellowship-trained at one of Turkey's premier oncology centers

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.